Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health monitoring news

Show

From To
Computer models predict how patients will respond to HIV drugs

Results of a new study demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. Crucially for patients in poorer countries, the models do not require the results of expensive drug resistance tests to make their predictions. The study also showed that the models were able to identify alternative drug combinations that were predicted to work in cases where the treatment used in the clinic had failed, suggesting that their use could avoid treatment failure.

Published
14 March 2013
From
Eurekalert Inf Dis
Routine viral load monitoring almost halves risk of virologic failure in 18-month Kenyan study

Six-monthly viral load testing of patients taking antiretroviral therapy (ART) at primary health clinics in rural Kenya reduced the risk of virologic failure at 18 months of

Published
12 March 2013
By
Lesley Odendal
MSF research points to ways to expand viral load testing in developing countries

At the 20th Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, the international medical humanitarian organization Médecins Sans Frontières (MSF) presented data today on strategies to reduce the costs and complexity of rolling out routine viral load monitoring in developing countries.

Published
07 March 2013
From
Médecins Sans Frontières press release
HIV treatment for children is safe and highly effective without laboratory monitoring in large African trial

Children did just as well on antiretroviral therapy without routine laboratory monitoring of CD4 cell counts or drug side-effects as those who received regular monitoring during four

Published
05 March 2013
By
Keith Alcorn
Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform

Alere Inc. announced that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates Foundation to support development of a point-of-care nucleic acid test for tuberculosis and to expand production facilities for this test and for a point-of-care viral load test.

Published
02 March 2013
From
Alere
Couples study in Uganda finds no HIV infections from partners on antiretroviral therapy

A longitudinal cohort study of heterosexual couples in Uganda has found more evidence of the efficacy of antiretroviral therapy (ART) in curbing HIV infection within the community. The study

Published
18 February 2013
By
Gus Cairns
Tenofovir, atazanavir/ritonavir and Kaletra associated with kidney problems in patients taking HIV therapy

Data from a large study into the safety of anti-HIV drugs suggest that the antiretrovirals tenofovir (Viread, also in Truvada, Atripla and Eviplera), atazanavir (Reyataz) and lopinavir/ritonavir

Published
15 February 2013
By
Michael Carter
UNITAID-financed project to increase access to new HIV monitoring technology

UNITAID and France Expertise Internationale (FEI) signed a US$ 2.4 million agreement to implement the “OPP-ERA” project which will stimulate the market entry of new manufacturers and suppliers of HIV Viral Load Test (VLT) technologies, bringing an innovative solution to meet the HIV monitoring and diagnostics needs in resource-limited settings.

Published
15 February 2013
From
UNITAID
Was higher viral load responsible for the African HIV epidemic?

Researchers from Cornell University in New York have found that the average HIV viral load of people not taking antiretroviral medication (ART) in Africa, and especially in southern

Published
12 February 2013
By
Gus Cairns
Screening can reduce number of patients in need of a doctor's time in busy South African clinic

Screening patients to identify those who are stable on treatment in a high-volume, large, urban, public-sector clinic in Johannesburg, South Africa has the potential to reduce total doctor

Published
29 January 2013
By
Carole Leach-Lemens
← First12345...39Next →

Filter by country